INTRODUCTION
The byproducts of hepatic drug metabolism are often oxidants or electrophiles which readily react with important biological moleculesY-3) Under ideal conditions, reactive metabolites are removed from the liver by a multitude of enzymes that have evolved for this purpose. Yet in certain situations these metabolites may accumulate. The resulting condition is broadly termed "oxidative stress" and leads to potentially dangerous alterations in hepatic structure and function. (4) Oxidative stress is demonstrably reduced in vitro with direct-acting antioxidants such as tocopherols and melatonin. In animal and human studies, however, the benefits of antioxidant use are far less apparent. The reason for this experimental incongruity is still unclear. One suggestion is that, in whole animal models, it is difficult to achieve adequate antioxidant concentrations anhe desired site of action. (5; 6) Alpha-tocopherol, for example-;1ends to accumulate in cellular membranes, and therefore has limited ability to quench reactive molecules within the cytoplasm. Many free radical-scavenging agents are also hypothesized to act as prooxidants, which may explain the observation that high doses of antioxidant vitamins actually increase morbidity and mortality. (7) (8) (9) (10) Many researchers are now looking toward the use of indirect antioxidants as a treatment for oxidative stress. In contrast to direct agents, such as the previously-mentioned antioxidant vitamins, indirect antioxidants do not interact with reactive metabolites or free radicals. (11) Sulforaphane (SFN), an isothiocyanate derived from Brassica vegetables, is a prototypical indirect antioxidant. Rather than reducing reactive metabolites, SFN induces Nrf2, a transcription factor that regulates cellular defense against toxicity. (12; 13) The proposed mechanism of defense is an interaction between SFN and Keap1, a substrate adaptor for the E3 ubiquitin ligase CuI3. (14; 15) During homeostasis Nrf2 is 'found in the cytoplasm, where it binds Keap1. In the absence 1 of stressors, Nrf2 and Keap1 remain bound, and Keap1 will eventually facilitate proteasomal degradation of Nrf2. Conversely, if electrophiles or oxidants are present, they will disrupt the bond between Nrf2 and Keap1, allowing Nrf2 to translocate to the nucleus and bind antioxidant response elements (AREs) in DNA. (16; 17) In particular, it is the electrophilic central carbon atom of SFN's -N=C=S side chain which theoretically disrupts the Nrf2-Keap1 bond, as this carbon can readily form thionoacyl adducts.(lS; 19) Following alkylation, Nrf2 would then be free to bind AREs which regulate the transcription of genes encoding cytoprotective enzymes, e.g., heme oxygenase 1 (Fig. 1) .
The purpose of the present study was to determine the ability of SFN to prevent toxicity in an established model of oxidative stress. Acetaminophen (APAP) was chosen because, though it is safe within its intended dose range, it causes a concentration-dependent and easily reproducible injury to hepatocytes at larger doses. (20) APAP's toxicity is mediated in part by its oxidative byproduct NAPQI, which can drastically deplete glutathione reserves.(21; 22) Despite substantial evidence of SFN's protective properties, there are no FDA-approved therapies for oxidative injury that incorporate indirect antioxidants. The results presented here further support the need for indirect antioxidants in clinical practice.
MATERIALS AND METHODS

Animals and treatments
Male C57BLl6J mice (6-8 weeks old) were purchased from Jackson Laboratory (Bar Harbor, ME). Mice were housed in a pathogen-free barrier facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, and procedures were approved by the local Institutional Animal Care and Use Committee. All diets were switched from standard laboratory chow to AIN-76A purified diet one week prior to the study, since impurities found in standard laboratory chow may create experimental variability. Food and tap water were allowed ad libitum.
In experiments designed to test the effects of SFN alone, mice were administered SFN (10 mg/kg i.g. diluted in water; LKT Laboratories, St. Paul, MN) or water for 4 days q.a.m. Groups -of mice were selected to be euthanized at six or 24 hours after the last i.g. dOSing. In experiments designed to test the protective effects of SFN on APAP overdose, mice were administered SFN (10 mg/kg i.g.) or water for 4 days q.a.m. On the following day, mice were injected with APAP (300 mg/kg i.p.; Sigma-Aldrich, St. Louis, MO). Six hours after APAP injection (24 h after last i.g. SFN or water), the mice were euthanized.
Regardless of experimental treatment, procedures used in harvesting tissue were the same. Mice were euthanized with ketamine/xylazine (100/15 mg/kg i.m.), and their blood and livers were collected for later analysis. Blood was collected from the vena cava just prior to sacrifice by exsanguination and citrated plasma was stored at -80°C for later analysis. Portions of liver tissue were snap-frozen in liquid nitrogen, frozen-fixed in OCT-Compound (Tissue-Tek OCT compound, Sakura Finetek, Torrance, CA), or fixed in 10% neutral buffered formalin for subsequent sectioning and mounting on microscope slides. Some snap-frozen liver was homogenized in 4.4% metaphosphoric acid for detection of glutathione.
Biochemical analyses and histology
Plasma levels of aminotransferases (AL T) and hepatic levels of triglycerides were determined using standard kits (Thermotrace, Melbourne, Australia). Paraffin-embedded sections of liver were stained with hematoxylin & eosin (H&E). Red blood cell extravasation in the livers was assessed by staining tissue sections for chloroacetate esterase, a marker for RBCs, using the naphthol AS-D chloroacetate esterase (CAE) kit (Sigma, St. Louis MO).
Adducts of 4-hydroxynonenal (lipid peroxidation) were detected by immunohistochemistry as described previously. (23) Quantitation of glutathione content and glutathione reductase activity Total cellular glutathione content was quantitated colorimetrically from liver samples using a modified version of the method described by Rahman. (24) A 10% solution of tissue homogenate (w/v) was prepared in 4.4% meta phosphoric acid using an all-glass Tenbroeck homogenizer, and kept on ice. After standing for 20-40 min, the homogenate was centrifuged for 1 min (10,000 x g), and the supernatant collected. Twenty tJl of the supernatant were added to each well of a microtiter plate and incubated with 120 tJl of a solution containing potassium phosphate buffer (pH 7.S), 10 mM EDTA, 2 mM S,S'-dithiobis(2-nitrobenzoic acid) (DTNB) and 230 U/mL glutathione reductase (GR, EC 1.6.4.2, Sigma-Aldrich, St. Louis, MO). After allowing 60 seconds for conversion of GSSG to GSH, 60 tJl of buffered NADPH solution was added, and the absorbance was read for S minutes at 412 nm during the linear portion of the reaction. Total glutathione was calculated from a standard curve prepared with purified GSH. Results were reported as nmol GSH per g tissue wet weight.
To determine GR activity, liver tissue was homogenized in a phosphate buffer (pH 7.S) containing 1 mM DTT and centrifuged for 10 min (10,000 x g) to clear the homogenate.
Twenty tJl of each sample were then added to each well of a microtiter plate and incubated for 60 sec with a solution containing phosphate buffer, 2 mM GSSG, and 1 mM NADPH. The absorbance was read for S min at 412 nm, and enzyme activity was calculated from a standard curve of purified GR. The protein concentration of the homogenate was subsequently measured according to the method of Bradford. (25) After adjusting for protein concentration, glutathione reductase activity was reported as units of activity/mg protein.
Microsomal isolation and cytochrome P450 activity determination
Expression and activity data were obtained for cytochrome P450 2E1 (CYP2E1), the microsomal enzyme that generates NAPQI. Microsomes were isolated according to a protocol adapted from those of COX(26) and Falkner. (27) Briefly, liver tissue was kept on ice and homogenized with a Teflon pestle in a buffer containing 50 mM Tris-HCI (pH 7.4), 225 mM mannitol and 75 mM sucrose. The homogenate was spun at 15,000 x 9 for 20 minutes, after which the supernatant was collected and spun at 436,000 x 9 for an additional 20 min. The pellet remaining was next resuspended in a buffer of 250 mM mannitol, 0.5 mM EGTA, and 5mM HEPES (pH 7.4) and centrifuged again at 9,000 x 9 for 30 min. The supernatant resulting from this centrifugation was collected, assessed for protein concentration, and stored at -SO° until kinetic analysis.
CYP2E1-mediated conversion of p-nitrophenol to 4-nitrocatechol was measured by spectrophotometer as described previously. (28; 29) Isolated microsomes were added to each well of a microtiter plate along with an assay buffer containing 100 mM sodium phosphate (pH 6.S), 0.1 mM p-nitrophenol, and 1mM NADPH. After incubating for 10 min at 37°, the absorbance was read at 4S0 nm for 12 min and concentration values were interpolated from a standard curve of 4nitrocatechol dissolved in sodium phosphate buffer. Activity was determined from the change in 4-nitrocatechol concentration per unit time.
Immunoblots
All buffers used for protein extraction contained protease, tyrosine phosphatase, and serine/threonine phosphatase inhibitor cocktails (Sigma, St. Louis, MO). Nuclear proteins were isolated according to the method of Dignam et al. (30) A sample of liver tissue (50-100 mg) from each animal was homogenized in a pre-chilled Dounce glass tissue grinder containing 500 IJL hypotonic buffer (1.5 mM MgCI 2 , 1 mM KCI, .5 mM DTT,10 mM HEPES, pH 7.6). The homogenate was placed on ice for 15 minutes, then vigorously mixed with 30 IJl of a 10% NP-40 solution and centrifuged for 30 sec at 16 ,000 x g. The supernatant (cytosolic fraction) was transferred to a separate tube and the pellet was mixed with 70 IJl of resuspension buffer (50% v/v glycerol, 420 mM NaCI, .25 mM EDTA, .5 mM DTT, 10 mM HEPES, pH 7.6). After the resuspended samples were agitated on ice for 15 min, they were then spun for 5 min at 16,000 x g, and the supernatant (nuclear fraction) was collected and stored at -80°C.
Nuclear and cytosolic proteins were loaded onto SDS-polyacrylamide gels of 10% (w/v) acrylamide followed by electrophoresis and Western blotting onto PVDF membranes (Hybond P, GE Healthcare, Piscataway, NJ). Primary antibodies against Nrf2 and GAPDH (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were used. Bands were visualized using an ECl kit (Pierce, Rockford, Il) and Hyperfilm (GE Healthcare, Piscataway, NJ).
RNA isolation and real-time RT -peR
Message levels of select genes were detected by real-time reverse-transcriptase PCR.
Total RNA was extracted from liver tissue samples by a guanidium thiocyanate-based method (Tel-Test, Austin, TX). RNA concentrations were determined spectrophotometrically, and cDNA was synthesized from 1 IJg total RNA using an MMlV reverse transcriptase kit (Quanta Biosciences, Gaithersburg, MD). The cDNA was added to a mixture containing pre-made primers and probes (Applied Biosystems, Foster City, CA) and a ready-to-use reaction buffer (Quanta).
Amplification reactions were carried out in the StepOne™ sequence detection system (Applied Biosystems). The comparative C T method was used to determine fold differences between samples and the calibrator gene, ~-actin.
Statistical analyses
Results are reported as means ± SEM (n = 4-7). ANOVA with Bonferroni's post-hoc test (for parametric data) or Mann-Whitney Rank Sum test (for non parametric data) was used for the determination of statistical significance among treatment grou ps, as appropriate. A p value less than 0.05 was selected before the study as the level of significance.
RESULTS
SFN treatment protected mice from necrosis caused by APAP
Elevated plasma levels of transaminases (e.g., ALT and AST) indicate damage to cell membranes and may be evidence of widespread liver dysfunction.(31) As expected, APAP overdose caused an average elevation in circulating AL T of >200-fold, and an elevation in AST of -100-fold, compared with controls. However, pretreatment with sulforaphane attenuated the increase in transaminases. On average, sulforaphane-treated mice had roughly half the transaminase activity of mice that did not receive sulforaphane (Fig. 2) . Transaminase data was paralleled by hepatic histology, as assessed by hematoxylin and eosin staining (Fig. 3A) . APAP caused necroinflammatory liver damage at pericentral regions of the liver in all mice, but the size of the necrotic areas was visibly diminished by SFN. APAP overdose also caused an increase in hemorrhagic necrosis, which is seen after chloroacetate esterase staining as an infiltraticrh of red blood cells into necrotic areas (Fig. 38) . SFN reduced the extravasation of red blood cells from pericentral foci, consistent with the observed changes in AL T, AST, and cellular morphology.
SFN decreased indices of oxidative stress
Glutathione is the first line of defense against APAP toxicity(32): APAP's toxic metabolite NAPQI is primarily removed by conjugation with GSH. In an experiment comparing the effects of SFN alone to control treatment, SFN was found to increase total hepatic glutathione (>1.2x on average; Fig. 4) . A similar effect on glutathione was seen after APAP overdose. In control mice that were fasted overnight, glutathione content was measured at -3400 nmol/gram of tissue.
After APAP injection, glutathione was reduced by half (-1500 nmol/g). With previous SFN administration, however, glutathione depletion was blunted (-2500 nmol/g) (Fig. 5, GSH+GSSG) .
Glutathione reductase activity was also significantly reduced by APAP. Enzyme activity in control mice averaged 35 units/g protein, but APAP overdose reduced this activity to -27 U/g. SFN pretreatment maintained the catalytic activity of GR at 35 U/g even after APAP (Fig. 5, GR) .
Lipid peroxidation strongly correlates with the availability of glutathione.(33; 34) As expected, the lipid peroxidation product 4-hydroxynonenal was detected over a substantial area of liver tissue after APAP intoxication (Fig. 6) . Though the characteristic brown stain indicating membrane lipid oxidation was present in all animals after APAP injection, this staining was more diffuse in mice that were pretreated with SFN. Lipid peroxidation, like necrosis, was largely confined to pericentral areas of the liver.
SFN did not inhibit CYP2E1, but induced Nrf2
The microsomal drug-metabolizing enzyme Cytochrome P450 2E1 (CYP2E1), found abundantly in the liver, is the primary P450 isozyme involved in NAPQI formation.
Correspondingly, many of the substances that prevent APAP intoxication work by inhibiting CYP2E1 and therefore reducing the formation of NAPQI. At this dose of SFN, however, no inhibition of CYP2E-1 was observed (Fig. 7) . The average activity of CYP2E1 protein in watertreated mice was 0.57 nmol/mg/min. In comparison the average CYP2E1 activity of SFN-treated mice was 0.54 nmol/mg/min, which was not statistically different.
Though SFN had no apparent effect on CYP2E1, it caused a robust increase in Nrf2 protein (Fig. 8) . Six hours after SFN treatment, Nrf2 was present in both nuclear and cytosolic cell fractions at levels roughly 2x greater than control. The ratio of nuclear Nrf2 to cytosolic Nrf2 was unaffected by treatment.
SFN did not significantly increase the mRNA levels of antioxidant genes
Because Nrf2 is a transcription factor for antioxidant-related genes, the mRNA levels of such genes should indirectly indicate the presence of Nrf2 in the nucleus. Two well-studied antioxidant genes were chosen as potential representatives of increased nuclear localization: heme oxygenase 1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (Nq01).
Six hours after SFN there is an apparent trend toward increased transcription of Nqo1 and HO-1. This trend is not observed at 24 hours after SFN. At neither time was there a significant difference in transcription between treated subjects and controls.
DISCUSSION
Oxidative stress is a known mediator of several pathologies, such as drug-induced liver failure. In spite of this, it has been shown that compounds that directly interact with oxidant species are often ineffective, and at times may worsen clinical outcomes. Sulforaphane was used here to investigate the ability of indirect antioxidants to prevent liver injury due to acetaminophen overdose. In contrast to direct antioxidants, SFN prevented liver damage and decreased the levels of several biomarkers for oxidative stress.
As explained in the Introduction, SFN is hypothesized to act through Nrf2, a transcription factor for antioxidant genes. The immunoblot data presented here support this hypothesis. After In parallel to its direct effect on Nrf2, SFN acted on some of the downstream targets of the transcriptional pathway. Mice treated with SFN had substantial augmentation of total cellular glutathione and glutathione reductase activity. These same mice were also protected from liver injury. Implied here is a specific, Nrf2-mediated mechanism by which SFN was protective.
Maintenance of cellular thiols is especially important after acetaminophen overdose. SFN-treated animals maintained total cellular glutathione better than untreated animals; therefore, they were better able to remove the toxic APAP metabolite NAPQI before it could cause more extensive hepatic damage.
It must be noted that SFN, for all of its effects on Nrf2 and Nrf2's downstream targets, did not appear to influence mRNA levels of the antioxidant genes Nqo 1 and HO-1. The reason for this is not immediately clear and might be attributed to several variables. Response to SFN has been shown to differ according to species, target tissue, dose, and method of administration. The dose chosen for this experiment -10 mg/kg/day -is in between those chosen by Thimmulappa and Robbins, being equivalent to 56.4 ~mol/kg/day. Due to the different times and routes of administration used in each study, however, it is difficult to extrapolate a cause for the variation in Nq01 mRNA levels. Furthermore, at this time there are no published studies of hepatic mRNA expression using SFN at or near 10 mg/kg. In the future it will be necessary to test a wider assortment of genes over a range of doses so that SFN's effects on gene expression may be better characterized.
Taken together, the results of this study indicate that SFN prevents acute liver injury after acetaminophen overdose. Specifically, SFN protected the liver by preventing the oxidative stress that invariably precedes APAP-induced hepatic failure. The data presented here support the role of alleviation of oxidative stress in APAP overdose and suggest a potential role for indirect antioxidants in clinical practice.
SUMMARY AND CONCLUSIONS
APAP overdose is the leading cause of fulminant hepatic failure, (38) - (1) .... Male C57BLl6J mice were treated with water or SFN alone and immunoblots were performed as described in Methods. Representative immunoblots for Nrf2 at the 6 h time point are shown (top panel). Nrf2 protein levels were normalized to loading controls and quantified by densitometry (bottom panels).
